Galena Biopharma's P2P Acquisition

Galena Biopharma raised a round of funding on December 30, 2017. Investors include Sellas.

Galena Biopharma (Nasdaq: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of ca…

Articles about Galena Biopharma's P2P Acquisition: